Search for a command to run...
Nexus Surgical And Medicare Ltd. lags significantly behind its peers in terms of growth and profitability, reflecting a challenging operational environment. While other companies demonstrate strong financial metrics, Nexus shows no revenue growth or profitability indicators, making it less attractive to investors. However, certain peers offer compelling value opportunities and growth potential, which could be more appealing for investment.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
Nexus Surgical And Medicare Ltd. | ₹18.04 | ₹9.87Cr | 19.86 | - | - |
MOTILALOFS | ₹895.65 | ₹53,677.56Cr | 38.22 | 18.74% | 1.35 |
MCX | ₹7,790.70 | ₹39,731.32Cr | 95.79 | 28.14% | - |
ANGELONE | ₹2,266.95 | ₹20,526.27Cr | 19.50 | 38.76% | 0.86 |
CHOICEIN | ₹790.80 | ₹16,263.24Cr | 2353.57 | 23.09% | 0.57 |
IIFLCAPS | ₹304.75 | ₹9,446.67Cr | 16.42 | 34.69% | 0.39 |
DHANI | ₹62.46 | ₹3,823.48Cr | -73.84 | 1.39% | 0.18 |